$BIIB
BIOGEN INC. Stock $biib

$biib Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000087504515000034 Filed on October 21, 2015

Income Statement

Concept	2015 Q3	2014 Q3
Revenue	$2.778B	$2.511B
YoY Change	10.61%	37.4%
Cost Of Revenue	$310.0M	$302.6M
YoY Change	2.43%	28.95%
Gross Profit	$2.468B	$2.209B
YoY Change	11.73%	38.65%
Gross Profit Margin	88.84%	87.95%
Selling, General & Admin	$477.8M	$570.4M
YoY Change	-16.24%	40.65%
% of Gross Profit	19.36%	25.83%
Research & Development	$519.9M	$417.2M
YoY Change	24.62%	1.75%
% of Gross Profit	21.07%	18.89%
Depreciation & Amortization	$151.6M	$175.4M
YoY Change	-13.57%	18.92%
% of Gross Profit	6.14%	7.94%
Operating Expenses	$997.7M	$987.6M
YoY Change	1.02%	21.09%
Operating Profit	$1.372B	$1.153B
YoY Change	19.02%	68.37%
Interest Expense	$15.60M	$7.400M
YoY Change	110.81%	12.12%
% of Operating Profit	1.14%	0.64%
Other Income/Expense, Net	-$15.40M	-$16.29M
YoY Change	-5.46%	251.08%
Pretax Income	$1.356B	$1.136B
YoY Change	19.37%	67.13%
Income Tax	$330.1M	$274.8M
% Of Pretax Income	24.34%	24.18%
Net Earnings	$965.6M	$856.9M
YoY Change	12.69%	75.74%
Net Earnings / Revenue	34.76%	34.12%
Basic Earnings Per Share	$4.16	$3.63
Diluted Earnings Per Share	$4.15	$3.62
COMMON SHARES
Basic Shares Outstanding	232.2M shares	236.2M shares
Diluted Shares Outstanding	232.6M shares	237.0M shares

Balance Sheet

Concept	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.843B	$1.861B
YoY Change	213.97%	178.18%
Cash & Equivalents	$4.089B	$1.186B
Short-Term Investments	$1.753B	$675.0M
Other Short-Term Assets	$861.9M	$396.5M
YoY Change	117.39%	92.8%
Inventory	$918.9M	$753.1M
Prepaid Expenses
Receivables	$1.328B	$1.091B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$9.271B	$4.372B
YoY Change	112.05%	65.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.028B	$1.724B
YoY Change	17.61%	-4.54%
Goodwill	$2.409B	$1.541B
YoY Change	56.3%	27.3%
Intangibles	$4.181B	$4.130B
YoY Change	1.25%	-9.83%
Long-Term Investments	$2.834B	$1.929B
YoY Change	46.92%	90.99%
Other Assets	$892.2M	$565.5M
YoY Change	57.77%	-11.09%
Total Long-Term Assets	$11.46B	$9.332B
YoY Change	22.78%	8.43%
TOTAL ASSETS
Total Short-Term Assets	$9.271B	$4.372B
Total Long-Term Assets	$11.46B	$9.332B
Total Assets	$20.73B	$13.70B
YoY Change	51.26%	21.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$251.2M	$233.6M
YoY Change	7.53%	40.14%
Accrued Expenses	$832.0M	$847.0M
YoY Change	-1.77%	30.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.000M	$3.000M
YoY Change	66.67%	0.0%
Total Short-Term Liabilities	$2.634B	$1.941B
YoY Change	35.73%	27.78%
LONG-TERM LIABILITIES
Long-Term Debt	$6.529B	$584.0M
YoY Change	1017.98%	-15.97%
Other Long-Term Liabilities	$861.4M	$658.3M
YoY Change	30.86%	8.18%
Total Long-Term Liabilities	$861.4M	$658.3M
YoY Change	30.86%	8.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.634B	$1.941B
Total Long-Term Liabilities	$861.4M	$658.3M
Total Liabilities	$10.16B	$3.273B
YoY Change	210.44%	4.76%
SHAREHOLDERS EQUITY
Retained Earnings	$12.00B	$8.400B
YoY Change	42.84%	42.58%
Common Stock	$124.0K	$129.0K
YoY Change	-3.88%	0.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.612B	$2.085B
YoY Change	25.27%	20.87%
Treasury Stock Shares
Shareholders Equity	$10.57B	$10.43B
YoY Change
Total Liabilities & Shareholders Equity	$20.73B	$13.70B
YoY Change	51.26%	21.81%

Cashflow Statement

Concept	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	$965.6M	$856.9M
YoY Change	12.69%	75.74%
Depreciation, Depletion And Amortization	$151.6M	$175.4M
YoY Change	-13.57%	18.92%
Cash From Operating Activities	$895.4M	$914.1M
YoY Change	-2.05%	36.05%
INVESTING ACTIVITIES
Capital Expenditures	-$229.2M	-$62.60M
YoY Change	266.13%	-21.85%
Acquisitions
YoY Change
Other Investing Activities	-$760.8M	-$478.0M
YoY Change	59.16%	95.74%
Cash From Investing Activities	-$990.0M	-$540.6M
YoY Change	83.13%	66.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.908B	-35.10M
YoY Change	-8383.76%	-88.98%
NET CHANGE
Cash From Operating Activities	895.4M	914.1M
Cash From Investing Activities	-990.0M	-540.6M
Cash From Financing Activities	2.908B	-35.10M
Net Change In Cash	2.813B	338.4M
YoY Change	731.26%	1066.9%
FREE CASH FLOW
Cash From Operating Activities	$895.4M	$914.1M
Capital Expenditures	-$229.2M	-$62.60M
Free Cash Flow	$1.125B	$976.7M
YoY Change	15.14%	29.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	127300000	USD
CY2014	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P15M
	biib	Adjustments To Product Revenue Reserves Relating To Sales In Prior Years AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears	37000000	USD
CY2014Q4	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	126800000	USD
CY2015Q3	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	127500000	USD
CY2014Q4	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	126900000	USD
	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P13M
	biib	Current Provisions To Product Revenue Reserves Relating To Sales In Current Year CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear	1636400000	USD
	biib	Debt Instrument Make Whole Provision Redemption Price Percentage DebtInstrumentMakeWholeProvisionRedemptionPricePercentage	1.01
CY2014Q4	biib	Due From Unconsolidated Joint Business DueFromUnconsolidatedJointBusiness	283360000	USD
CY2015Q3	biib	Due From Unconsolidated Joint Business DueFromUnconsolidatedJointBusiness	319788000	USD
CY2014Q3	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.020
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.019
CY2015Q3	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.021
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.020
CY2014Q4	biib	Employeerelatedliabilitiesnoncurrent Employeerelatedliabilitiesnoncurrent	200700000	USD
CY2015Q3	biib	Employeerelatedliabilitiesnoncurrent Employeerelatedliabilitiesnoncurrent	218400000	USD
CY2015Q3	biib	Employeestockpurchaseplanmaximumshares Employeestockpurchaseplanmaximumshares	6200000	shares
CY2015Q3	biib	Finitelivedintangibleassetsfutureamortization Finitelivedintangibleassetsfutureamortization	1596900000	USD
CY2014Q3	biib	Gain On Sale Of Rights GainOnSaleOfRights	4379000	USD
	biib	Gain On Sale Of Rights GainOnSaleOfRights	12138000	USD
CY2015Q3	biib	Gain On Sale Of Rights GainOnSaleOfRights	0	USD
	biib	Gain On Sale Of Rights GainOnSaleOfRights	0	USD
	biib	Interest In Subsidiary InterestInSubsidiary	1.00
CY2014Q4	biib	Inventory Various Programs Gross InventoryVariousProgramsGross	6300000	USD
CY2015Q3	biib	Inventory Various Programs Gross InventoryVariousProgramsGross	54300000	USD
CY2014Q4	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	7900000	USD
CY2015Q3	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	10700000	USD
	biib	Maximum Term For Accounts Receivable MaximumTermForAccountsReceivable	P90D
	biib	Minimum Term For Accounts Receivable MinimumTermForAccountsReceivable	P30D
CY2014Q3	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	0	USD
	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	0	USD
CY2015Q3	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	300000	USD
	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	0	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	8.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	11.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.64
CY2014Q4	biib	Overnightreverserepurchaseagreementspercentoftotalassets Overnightreverserepurchaseagreementspercentoftotalassets	0.021
CY2015Q3	biib	Overnightreverserepurchaseagreementspercentoftotalassets Overnightreverserepurchaseagreementspercentoftotalassets	0.009
	biib	Payment Terms Of Accounts Receivable PaymentTermsOfAccountsReceivable	30 to 90 days
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Current Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear	1151300000	USD
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear	321200000	USD
CY2014Q3	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	56600000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	186100000	USD
CY2015Q3	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	25500000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	159200000	USD
CY2014Q3	biib	Unconsolidated Joint Business UnconsolidatedJointBusiness	290678000	USD
	biib	Unconsolidated Joint Business UnconsolidatedJointBusiness	890859000	USD
CY2015Q3	biib	Unconsolidated Joint Business UnconsolidatedJointBusiness	337181000	USD
	biib	Unconsolidated Joint Business UnconsolidatedJointBusiness	1005302000	USD
CY2014Q4	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	72100000	USD
CY2015Q3	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	23300000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000875045
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	222903109	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BIOGEN INC.
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	229178000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	251228000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1292445000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1327780000	USD
CY2014Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	172400000	USD
CY2015Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	154900000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1186400000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1320500000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27700000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-38000000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-59488000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-157416000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4196156000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1342373000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	144400000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	58900000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	193600000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	28300000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	167600000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	122431000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	382515000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	98065000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	285972000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2014Q4	us-gaap	Assets Assets	14314781000	USD
CY2015Q3	us-gaap	Assets Assets	20728368000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	4672154000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	9270873000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2112800000	USD
CY2015Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3700800000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2111100000	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3700900000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	700000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2300000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2400000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2200000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2112800000	USD
CY2015Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	3700800000	USD
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	640460000	USD
CY2015Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	1753499000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1345200000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1820300000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1343700000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1820100000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	640800000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1753000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	640500000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1753500000	USD
CY2014Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	400000	USD
CY2015Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	700000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1300000	USD
CY2014Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	100000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	300000	USD
CY2015Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2000000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2900000	USD
CY2014Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	1470652000	USD
CY2015Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	1947354000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	265500000	USD
CY2015Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	479500000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	200000000	USD
CY2015Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	301900000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	602562000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1186281000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1204924000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4089003000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	601946000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2914437000	USD
CY2014Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	716300000	USD
CY2015Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	3804200000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	129000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	124000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	845549000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2041078000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	909231000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2617511000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	738000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-7660000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-53586000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-49053000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	844811000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2048738000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	962817000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2666564000	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	302639000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	873771000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	310028000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	908579000	USD
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	1363247000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4262136000	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	1406027000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4201661000	USD
CY2014Q4	us-gaap	Debt Current DebtCurrent	3136000	USD
CY2015Q3	us-gaap	Debt Current DebtCurrent	5171000	USD
CY2015Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	6000000000	USD
CY2014Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	647200000	USD
CY2015Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	6680000000	USD
	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	less than 90 days
	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2015Q3	us-gaap	Debt Issuance Costs DebtIssuanceCosts	47500000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-229273000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-185802000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	120900000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	58400000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	50656000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	136761000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	530508000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	444100000	USD
CY2014	us-gaap	Derivative Higher Remaining Maturity Range1 DerivativeHigherRemainingMaturityRange1	P15M
	us-gaap	Derivative Higher Remaining Maturity Range1 DerivativeHigherRemainingMaturityRange1	P15M
CY2014	us-gaap	Derivative Lower Remaining Maturity Range1 DerivativeLowerRemainingMaturityRange1	P1M
	us-gaap	Derivative Lower Remaining Maturity Range1 DerivativeLowerRemainingMaturityRange1	P1M
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.63
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.62
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.16
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	11.57
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-18227000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-30358000	USD
CY2014Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.242
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.258
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.243
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.246
CY2014Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2014Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.093
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.089
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.107
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.101
CY2014Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.007
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.011
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.015
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.012
CY2014Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.005
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.006
CY2014Q3	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.012
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2014Q3	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.012
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.012
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.012
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.005
CY2014Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.006
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.008
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.011
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.009
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	393800000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	214200000	USD
CY2014Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2300000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	7500000	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2800000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	8400000	USD
CY2014Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	16600000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	55400000	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6400000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	46000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	90423000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	70778000	USD
	us-gaap	Maximum Remaining Maturity Of Foreign Currency Derivatives1 MaximumRemainingMaturityOfForeignCurrencyDerivatives1	P15M
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	49433000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	46213000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-244000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-5887000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	274500000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	16500000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	21500000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	14500000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	14500000	USD
	us-gaap	Fair Value Measurements Changes In Valuation Techniques FairValueMeasurementsChangesInValuationTechniques	0
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3178600000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3464600000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	348800000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	94300000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	269100000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	275100000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	291000000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	318600000	USD
CY2014Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4800000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9500000	USD
CY2015Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4300000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-18800000	USD
CY2014Q3	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	7700000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	11500000	USD
CY2015Q3	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	8100000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	4200000	USD
CY2014Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-3100000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	13500000	USD
CY2015Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1100000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-300000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	1760249000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	2408854000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	649400000	USD
CY2015Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	-700000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1136288000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2795621000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1356419000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3681515000	USD
CY2014Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5394000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14932000	USD
CY2015Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6833000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12548000	USD
CY2015Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	49300000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	274774000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	721709000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	330093000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	904475000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	297057000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	63608000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	19283000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-174532000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	119890000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	150387000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-22904000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	121659000	USD
CY2014Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7207100000	USD
CY2015Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7645800000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4028507000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4181245000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	7400000	USD
	us-gaap	Interest Expense InterestExpense	22100000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	15600000	USD
	us-gaap	Interest Expense InterestExpense	28100000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	164200000	USD
CY2015Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	159700000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	804022000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	918921000	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	128300000	USD
CY2015Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	221500000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	511500000	USD
CY2015Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	537700000	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3600000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	8700000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	5400000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3500741000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	10161425000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14314781000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20728368000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2219706000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2633968000	USD
CY2015Q3	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P5Y
CY2015Q3	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	0	USD
CY2015Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	580283000	USD
CY2015Q3	us-gaap	Long Term Debt LongTermDebt	6529275000	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	600000	USD
CY2014Q2	us-gaap	Minority Interest MinorityInterest	3900000	USD
CY2014Q3	us-gaap	Minority Interest MinorityInterest	3200000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	5030000	USD
CY2015Q2	us-gaap	Minority Interest MinorityInterest	400000	USD
CY2015Q3	us-gaap	Minority Interest MinorityInterest	-5783000	USD
CY2014Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	0	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9100000	USD
CY2015Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	60000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	60000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-242608000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2984803000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1164698000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2746071000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2009252000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2675705000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	856858000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2051320000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	965622000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2715439000	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-738000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7660000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	53871000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	49053000	USD
CY2014Q3	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	4000000	USD
CY2015Q3	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	200000	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	100000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16290000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17030000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15413000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41288000	USD
CY2014Q4	us-gaap	Notes Payable NotesPayable	583400000	USD
CY2015Q3	us-gaap	Notes Payable NotesPayable	6514300000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1152578000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2812651000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1371832000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3722803000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	507500000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	549200000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	249400000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	341100000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	446943000	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	861882000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	617536000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	892221000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	12000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-5127000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2239000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1154000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-6000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-3021000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-1320000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-699000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-11000000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	19700000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	48242000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	64793000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-31171000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-40084000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	302000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	307000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	-187000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	-229000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-60254000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-71246000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-23504000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-61322000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11309000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10242000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-56391000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-97928000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-691000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1338000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-523000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-4632000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1819334000	USD
CY2015Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1918897000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	650096000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	861421000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	95711000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-31564000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4600000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7600000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7100000	USD
CY2014Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	103402000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	255367000	USD
CY2015Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	48961000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	359981000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	156557000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	13131000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	33620000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2998190000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2738584000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	4870142000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	198798000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	175000000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	550000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	180854000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	456885000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	44960000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	45509000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5930936000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-15336000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-62147000	USD
CY2014Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	625400000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1942871000	USD
CY2015Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2387900000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	3363374000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	856120000	USD
	us-gaap	Profit Loss ProfitLoss	2058980000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	1019493000	USD
	us-gaap	Profit Loss ProfitLoss	2764492000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1765683000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2027821000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	800000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-117700000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2674000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2083000	USD
CY2014Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	417174000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1393331000	USD
CY2015Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	519863000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1471140000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9283919000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11999358000	USD
CY2014Q3	us-gaap	Revenues Revenues	2511446000	USD
	us-gaap	Revenues Revenues	7062649000	USD
CY2015Q3	us-gaap	Revenues Revenues	2777859000	USD
	us-gaap	Revenues Revenues	7924464000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2117366000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5916423000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2391717000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6762605000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	570436000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1658732000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	477827000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1530083000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	119508000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	131537000	USD
CY2015Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000000	USD
CY2015Q3	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	1300000	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	10809010000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	10572726000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10814040000	USD
CY2015Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10566943000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	247100000	USD
CY2014Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	168058000	USD
CY2015Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	458672000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1200000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	9700000	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2611706000	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2611713000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	24000000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	483800000	USD
CY2015Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	610700000	USD
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	800000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	800000	shares
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	600000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	236972000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	237449000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	232612000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	234659000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	236217000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	236641000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	232191000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	234134000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments, and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0000875045-15-000034-index-headers.html	Edgar Link	pending
0000875045-15-000034-index.html	Edgar Link	pending
0000875045-15-000034.txt	Edgar Link	pending
0000875045-15-000034-xbrl.zip	Edgar Link	pending
biib-20150930.xml	Edgar Link	completed
biib-20150930.xsd	Edgar Link	pending
biib-20150930_cal.xml	Edgar Link	unprocessable
biib-20150930_def.xml	Edgar Link	unprocessable
biib-20150930_lab.xml	Edgar Link	unprocessable
biib-20150930_pre.xml	Edgar Link	unprocessable
biib-2015930x10q.htm	Edgar Link	pending
biib-2015930xex311.htm	Edgar Link	pending
biib-2015930xex312.htm	Edgar Link	pending
biib-2015930xex321.htm	Edgar Link	pending
biib-2015930_14rdpiechart.jpg	Edgar Link	pending
biib-2015930_15rdpiechart.jpg	Edgar Link	pending
biib-2015930_alpchart.jpg	Edgar Link	pending
biib-2015930_amortchart.jpg	Edgar Link	pending
biib-2015930_avxchart.jpg	Edgar Link	pending
biib-2015930_coschart.jpg	Edgar Link	pending
biib-2015930_elochart.jpg	Edgar Link	pending
biib-2015930_gainlosschart.jpg	Edgar Link	pending
biib-2015930_highlightschart.jpg	Edgar Link	pending
biib-2015930_investeechart.jpg	Edgar Link	pending
biib-2015930_noncontchart.jpg	Edgar Link	pending
biib-2015930_oiechart.jpg	Edgar Link	pending
biib-2015930_otherrevchart.jpg	Edgar Link	pending
biib-2015930_plegchart.jpg	Edgar Link	pending
biib-2015930_rdchart.jpg	Edgar Link	pending
biib-2015930_reserveperchart.jpg	Edgar Link	pending
biib-2015930_reserveschart.jpg	Edgar Link	pending
biib-2015930_sgachart.jpg	Edgar Link	pending
biib-2015930_taxexpchart.jpg	Edgar Link	pending
biib-2015930_taxperchart.jpg	Edgar Link	pending
biib-2015930_tecchart.jpg	Edgar Link	pending
biib-2015930_tyschart.jpg	Edgar Link	pending
biib-2015930_ujbchart.jpg	Edgar Link	pending
biogenlogostandard.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIIB
BIOGEN INC. Stock $biib

2015 Q3 Form 10-Q Financial Statement

#000087504515000034 Filed on October 21, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB BIOGEN INC. Stock $biib

2015 Q3 Form 10-Q Financial Statement

#000087504515000034 Filed on October 21, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB
BIOGEN INC. Stock $biib